This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Pathology & Laboratory Medicine  • Diabetes Mellitus  • Alert me on articles by topic  Social Bookmarking   What's this?

Gordon D. Schiff, MD; Seijeoung Kim, PhD; Nela Krosnjar; Mary F. Wisniewski, MSN; Judylin Bult, PharmD; Leon Fogelfeld, MD; Robert A. McNutt, MD

Arch Intern Med. 2005;165:574-577.

Background  Although diagnostic errors are important, they have received less attention than medication errors. Timely follow-up of abnormal laboratory test results represents a critical aspect of the diagnostic process, and failures at this step are a cause of delayed or missed diagnosis, resulting in suboptimal clinical outcomes and malpractice litigation. We linked laboratory and pharmacy databases to (1) explore the potential for linking laboratory and pharmacy databases to uncover diagnostic errors, and (2) determine the frequency of failed follow-up of elevated levels of thyroid-stimulating hormone (TSH).

Methods  We downloaded TSH test results for 2 consecutive years from a laboratory database and linked this database with a pharmacy database to screen for patients with TSH levels of 20 mU/mL or higher who were not receiving levothyroxine. Patients with elevated TSH levels lacking prescriptions were followed up by telephone and record review.

Results  During the 2-year period, 982 (2.7%) of 36 760 unique patients tested for TSH level had elevated TSH levels. Of these patients, 177 (18.0%) had no recorded levothyroxine prescriptions. We attempted to contact 177 patients with high TSH levels who were not taking thyroid medications and reached 123 (69.5%). Of the 123 patients we were able to reach, 12 in 2000 and 11 in 2001 were unaware of their abnormal test results or a diagnosis of hypothyroidism, representing 2.3% of 982 patients with elevated TSH levels. We were unable to reach another 54 patients (5.5% of the total number of patients with elevated TSH levels) by either telephone or mail.

Conclusions  By linking laboratory and pharmacy databases, we uncovered patients who did not undergo follow-up for abnormal TSH results. Conservatively, there was no follow-up for abnormal TSH results in more than 2% of patients, and another 5% of patients were lost to follow-up and possibly unaware of their results. Uncovering patients with missed diagnosis illustrates a potential use of linking laboratory and pharmacy databases to identify vulnerabilities in the care system and improve patient safety.

Author Affiliations: Division of General Medicine, Department of Medicine (Drs Schiff and Kim and Ms Krosnjar), Division of Infectious Diseases, Department of Medicine (Ms Wisniewski), Department of Pharmacy (Dr Bult), Division of Endocrinology, Department of Medicine (Dr Fogelfeld), John H. Stroger, Jr, Hospital of Cook County; Department of Medicine, Rush-Presbyterian-St Luke’s Medical Center (Drs Schiff and McNutt), Chicago, Ill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Failure to Recognize Newly Identified Aortic Dilations in a Health Care System With an Advanced Electronic Medical Record
Gordon et al.
ANN INTERN MED 2009;151:21-27.
ABSTRACT | FULL TEXT  

Management of Test Results in Family Medicine Offices
Elder et al.
Ann Fam Med 2009;7:343-351.
ABSTRACT | FULL TEXT  

Frequency of Failure to Inform Patients of Clinically Significant Outpatient Test Results
Casalino et al.
Arch Intern Med 2009;169:1123-1129.
ABSTRACT | FULL TEXT  

Prevalence of Delayed Clinician Response to Elevated Prostate-Specific Antigen Values
Nepple et al.
Mayo Clin Proc. 2008;83:439-445.
ABSTRACT | FULL TEXT